PPARα activation leading to hepatocellular steatosis and carcinomas (Homo sapiens)

From WikiPathways

Jump to: navigation, search
Liver X receptor pathwayIncrease, Phenotypic enzyme activityIncrease, Clonal Expansion of Altered Hepatic Foci Increase, cell proliferation (hepatocytes)Increase, hepatocellular adenomas and carcinomasCell cycleLipid Metabolism PathwayMitochondrial LC-Fatty Acid Beta-OxidationKE860: Decreased, Mitochondrial Fatty Acid Beta OxidationKE227: Activation, PPARαPPAR Alpha PathwayBranched-chain amino acid catabolismKE10106: Fatty Acid LysisKE140: Decreased, HSD17B10 expressionFatty liver cellsKE291: Accumulation, TriglycerideKE345: Liver steatosisKE66: Activation, ChREBPKE116: Activation, FASLiver X Receptor PathwayKE264: Activation, SREBP-1cAngiopoietin Like Protein 8 Regulatory PathwayKE167: Activation, LXRAMP-activated Protein Kinase (AMPK) SignalingKE89: Synthesis, De Novo FASterol Regulatory Element-Binding Proteins (SREBP) signallingFatty Acid Biosynthesis


Description

PFAS interaction with PPARalpha leading to liver carcinoma and liver steatosis

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

No bibliography


History

CompareRevisionActionTimeUserComment
129485view09:47, 30 April 2024SamBrussWP ID added
129483view09:40, 30 April 2024SamBrussNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
Increase, cell proliferation (hepatocytes)
AMP-activated Protein Kinase (AMPK) SignalingPathwayWP1403 (WikiPathways)
Angiopoietin Like Protein 8 Regulatory PathwayPathwayWP3915 (WikiPathways)
Branched-chain amino acid catabolismPathwayWP3556 (WikiPathways)
Cell cyclePathwayWP1393 (WikiPathways)
Fatty Acid BiosynthesisPathwayWP357 (WikiPathways)
Increase, Clonal Expansion of Altered Hepatic Foci
Increase, Phenotypic enzyme activity
Increase, hepatocellular adenomas and carcinomas
KE10106: Fatty Acid LysisEvent10106 (AOP-Wiki KE)
KE116: Activation, FASEvent116 (AOP-Wiki KE)
KE140: Decreased, HSD17B10 expressionEvent140 (AOP-Wiki KE)
KE167: Activation, LXREvent167 (AOP-Wiki KE)
KE227: Activation, PPARαEvent227 (AOP-Wiki KE)
KE264: Activation, SREBP-1cEvent264 (AOP-Wiki KE)
KE291: Accumulation, TriglycerideEvent291 (AOP-Wiki KE)
KE345: Liver steatosisEvent345 (AOP-Wiki KE)
KE66: Activation, ChREBPEvent66 (AOP-Wiki KE)
KE860: Decreased, Mitochondrial Fatty Acid Beta OxidationEvent860 (AOP-Wiki KE)
KE89: Synthesis, De Novo FAEvent89 (AOP-Wiki KE)
Lipid Metabolism PathwayPathwayWP3965 (WikiPathways)
Liver X Receptor PathwayPathwayWP2874 (WikiPathways)
Liver X receptor pathwayPathwayWP2874 (WikiPathways)
Mitochondrial LC-Fatty Acid Beta-OxidationPathwayWP368 (WikiPathways)
PPAR Alpha PathwayPathwayWP2878 (WikiPathways)
Sterol Regulatory Element-Binding Proteins (SREBP) signallingPathwayWP1982 (WikiPathways)

Annotated Interactions

No annotated interactions

Personal tools